Elite Pharmaceuticals Inc. (ELTP)

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q2 2018 Results - Earnings Call Transcript
Nov. 11, 2017 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q1 2018 Results - Earnings Call Transcript
Aug. 12, 2017 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q4 2017 Results - Earnings Call Transcript
June 15, 2017 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q3 2017 Results - Earnings Call Transcript
Feb. 13, 2017 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q2 2017 Results - Earnings Call Transcript
Nov. 10, 2016 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q1 2017 Results - Earnings Call Transcript
Aug. 16, 2016 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q4 2016 Results - Earnings Call Transcript
June 20, 2016 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q3 2016 Results - Earnings Call Transcript
Feb. 11, 2016 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q3 2015 Results - Earnings Call Transcript
Nov. 10, 2015 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceutical's (ELTP) CEO Nasrat Hakim on Q1 2016 Results - Earnings Call Transcript
Aug. 11, 2015 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceutical's (ELTP) CEO Nasrat Hakim on Q4 2015 Results - Earnings Call Transcript
June 16, 2015 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q3 2015 - Earnings Call Transcript
Feb. 18, 2015 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q2 2015 Results - Earnings Call Transcript
Nov. 19, 2014 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q1FY2015 Results - Earnings Call Transcript
Aug. 18, 2014 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q4 2014 Results - Earnings Call Transcript
July 1, 2014 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' CEO Discusses F3Q2014 Results - Earnings Call Transcript
Feb. 18, 2014 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals - Q2 2014 Earnings Call Transcript
Nov. 18, 2013 | Price: Free! | Source: Earnings Impact

Elite Pharmaceuticals - Q1 2014 Earnings Call Transcript
Aug. 15, 2013 | Price: Free! | Source: Earnings Impact

Elite Pharmaceuticals' CEO Discusses 2Q 2013 Results - Earnings Call Transcript
Aug. 15, 2013 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' CEO Discusses F4Q2013 Results - Earnings Call Transcript
June 24, 2013 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' CEO Discusses F3Q13 Results - Earnings Call Transcript
Feb. 19, 2013 | Price: Free! | Source: Seeking Alpha

Recent filings

Elite Pharmaceuticals Inc. Just Filed Its Quarterly Report: NOTE 22. SUBSEQUE... - Nov. 9, 2017

Elite Pharmaceuticals, Inc. Reports Financial Results For The Second Quarter Of Fiscal Year 2018 - Nov. 9, 2017

Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2018 Ended September 30, 2017 - Nov. 9, 2017

Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss Second Quarter Financial Results on September 10, 2017 - Nov. 7, 2017

CORRECTING and REPLACING – Elite Pharmaceuticals, Inc. - Nov. 7, 2017

Confidential treatment order - Oct. 11, 2017

Elite Pharmaceuticals Files ANDA for Oxycodone Hydrochloride Extended Release - Sept. 20, 2017

Caution Concerning Forward Looking - Sept. 7, 2017

Elite Pharmaceuticals to Present ELI-200 (SequestOx™) Data at PAINWeek 2017 National Conference - Aug. 30, 2017

Elite Pharmaceuticals Inc. Just Filed Its Quarterly Report: The following i... - Aug. 9, 2017

Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2018 Ended June 30, 2017 and Provides Conference Call Information - Aug. 9, 2017

Elite Pharmaceuticals, Inc. Reports Financial Results For The First Quarter Of Fiscal Year 2018 Ended June 30, 2017 And Provides Conference Call Information - Aug. 9, 2017

Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss First Quarter Financial Results on August 10, 2017 - Aug. 8, 2017

Elite Pharmaceuticals: Elite Announces Co-Development Of Four Additional Products With Sungen Pharma - July 28, 2017

Elite Announces Co-Development of Four Additional Products with SunGen Pharma - July 28, 2017

Elite Announces New Development and License Agreement with SunGen Pharma LLC - July 12, 2017

Confidential treatment order - July 12, 2017

Elite Pharmaceuticals: Elite Announces New Development And License Agreement With Sungen Pharma Llc - July 12, 2017

Elite Pharmaceuticals Reports Topline Results From A Pivotal Fed Bioequivalence Study For Sequestox™ - July 7, 2017

Elite Pharmaceuticals Reports Topline Results from a Pivotal Fed Bioequivalence Study for SequestOx™ - July 7, 2017

Elite Pharmaceuticals Inc. Just Filed Its Annual Report: Earnings (Loss) P... - June 14, 2017

Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2017 and Provides Conference Call Information - June 14, 2017

Elite Pharmaceuticals, Inc. Reports Financial Results For The Fiscal Year Ended March 31, 2017 And Provides Conference Call Information - June 14, 2017

Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss Financial Results on June 15, 2017 - June 13, 2017

Elite Pharmaceuticals Inc. Just Received a Notice of Effectiveness - June 5, 2017

Elite Pharmaceuticals Inc. just filed a prospectus, suggesting it plans to soon issue some securities - June 5, 2017

Registration statement under Securities Act of 1933 - June 2, 2017

Elite Pharmaceuticals Granted New Patent for Abuse Deterrent Technology - May 31, 2017

Elite Pharmaceuticals’ SequestOx™ Study Results Expected in July - May 25, 2017

Elite Pharmaceuticals Acquires Trimipramine Anda - May 22, 2017

Elite Pharmaceuticals Acquires Trimipramine ANDA - May 22, 2017

Registration statement under Securities Act of 1933 - May 10, 2017

Notice of Exempt Offering of Securities, item 06b - May 10, 2017

Major owner of Elite Pharmaceuticals Inc. just disposed of 158,017,321 shares - May 3, 2017

Entry into a Material Definitive - May 2, 2017

Entry into a Material Definitive - May 1, 2017

Entry into a Material Definitive - April 28, 2017

Elite Pharmaceuticals Files ANDA for Pain Product - April 4, 2017

Elite Pharmaceuticals, Inc. Initiates Pivotal Bioequivalence Fed Study for Reformulated SequestOx™ - March 13, 2017

Elite Pharmaceuticals Inc.'s SVP of Operations just picked up 110,849 shares - Feb. 27, 2017

Elite Pharmaceuticals Inc. director just picked up 72,040 shares - Feb. 27, 2017

Elite Pharmaceuticals Inc. director just picked up 68,518 shares - Feb. 27, 2017

Elite Pharmaceuticals Inc. director just picked up 133,019 shares - Feb. 27, 2017

Elite Pharmaceuticals Inc. director just picked up 88,679 shares - Feb. 27, 2017

Elite Pharmaceuticals Inc. director just picked up 88,679 shares - Feb. 27, 2017

Major owner of Elite Pharmaceuticals Inc. just picked up 2,216,992 shares - Feb. 27, 2017

Elite Pharmaceuticals, Inc. Reports Results for Third Quarter of Fiscal Year 2017 - Feb. 9, 2017

Elite Pharmaceuticals, Inc. Reports Results For Third Quarter Of Fiscal Year 2017 - Feb. 9, 2017

Elite Pharmaceuticals Inc. just filed a prospectus, suggesting it plans to soon issue some securities - Feb. 9, 2017

Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss 3rd Quarter 2017 Financial Results on February 13, 2017 - Feb. 7, 2017

Elite Reports On SequestOx™ FDA End-of-Review Meeting - Jan. 23, 2017

Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study for a Generic OxyContin® - Jan. 17, 2017

Elite Pharmaceuticals: Elite Provides Update On Sequestox™ New Drug Application - Dec. 22, 2016

Confidential treatment order - Dec. 22, 2016

Elite Provides Update on SequestOx™ New Drug Application - Dec. 22, 2016

Elite Pharmaceuticals Files ANDA for Hydrocodone and Acetaminophen Combo - Dec. 12, 2016

Elite Pharmaceuticals: As Of Close Of Business On - Nov. 17, 2016

Elite Pharmaceuticals, Inc. And Subsidiaries PART II – OTHER INFORMATION - Nov. 17, 2016

Elite Pharmaceuticals Inc. just filed a prospectus, suggesting it plans to soon issue some securities - Nov. 9, 2016

Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2017 and Provides Conference Call Information - Nov. 9, 2016

Elite Pharmaceuticals Inc. Just Filed Its Quarterly Report: Earnings (Loss) P... - Nov. 9, 2016

Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss 2nd Quarter 2017 Financial Results on November 10, 2016 - Nov. 7, 2016

Entry Into A Material Definitive - Sept. 1, 2016

Elite Pharmaceuticals: Elite Announces Development And License Agreement With Sungen Pharma Llc - Aug. 31, 2016

Elite Announces Development and License Agreement with SunGen Pharma LLC - Aug. 29, 2016

Elite Announces Development and License Agreement with SunGen Pharma LLC - Aug. 29, 2016

Major owner of Elite Pharmaceuticals Inc. just picked up 142,857,143 shares - Aug. 19, 2016

Elite Pharmaceuticals files ANDA to Market Generic Percocet - Aug. 10, 2016

Elite Pharmaceuticals, Inc. Reports Financial Results For The First Quarter Of Fiscal Year 2017 And Provides Conference Call Information - Aug. 9, 2016

Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2017 and Provides Conference Call Information - Aug. 9, 2016

Elite Pharmaceuticals Inc. Just Filed Its Quarterly Report: Earnings (Loss) P... - Aug. 9, 2016

Elite Pharmaceuticals Inc. just filed a prospectus, suggesting it plans to soon issue some securities - Aug. 9, 2016

OTCQB Certification - Aug. 1, 2016

Elite Pharmaceuticals Inc. just filed a prospectus, suggesting it plans to soon issue some securities - July 21, 2016

Regulation FD - July 21, 2016

Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss SequestOx™ Complete Response Letter on Monday, July 18, 2016 at 8:30 AM EDT - July 16, 2016

FDA Issues Complete Response Letter for SequestOx™ New Drug Application - July 15, 2016

Elite Pharmaceuticals Inc. just filed a prospectus, suggesting it plans to soon issue some securities - July 15, 2016

Elite Pharmaceuticals: Fda Issues Complete Response Letter For Sequestox™ New Drug Application - July 15, 2016

Elite Pharmaceuticals Inc. just filed a prospectus, suggesting it plans to soon issue some securities - July 14, 2016

Elite Pharmaceuticals Inc. Just Received a Notice of Effectiveness - July 13, 2016

General form for registration of securities under the Securities Act of 1933 - June 27, 2016

Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 - June 15, 2016

Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2016 and Provides Conference Call Information - June 15, 2016

Current report, items 2.02, 7.01, and 9.01 - June 15, 2016

Elite Pharmaceuticals Inc. Just Filed Its Annual Report: EARNINGS PER COMMO... - June 15, 2016

Elite Pharmaceuticals to Present SequestOx™ Data at the American Pain Society 35th Annual Scientific Meeting - May 9, 2016

Elite Pharmaceuticals Appoints Davis S. Caskey to Its Board of Directors - May 4, 2016

Elite Pharmaceuticals Inc. director just declared ownership of no shares of Elite Pharmaceuticals Inc. - May 4, 2016

Elite Pharmaceuticals Appoints Davis S. Caskey To Its Board Of Directors - May 4, 2016

CFO of Elite Pharmaceuticals Inc. just picked up 666,667 shares - May 3, 2016

Elite Pharmaceuticals Inc. director just declared ownership of no shares of Elite Pharmaceuticals Inc. - April 25, 2016

Elite Pharmaceuticals Inc. insider just picked up 4,000,000 shares - April 15, 2016

Elite Pharmaceuticals Announces Changes to their Board of Directors - April 12, 2016

Elite Pharmaceuticals Announces Changes To Their Board Of Directors - April 12, 2016

Statement of changes in beneficial ownership of securities - March 21, 2016

Elite Pharmaceuticals: Elite Announces U.S. Fda Priority Review Designation For Sequestox - March 17, 2016

Elite Announces U.S. FDA Priority Review Designation for SequestOx™ NDA - March 17, 2016

Elite Pharmaceuticals Inc. insider just disposed of 200,456 shares - Feb. 24, 2016

CFO of Elite Pharmaceuticals Inc. just picked up 122,325 shares - Feb. 18, 2016

Sorry, no schedule available for this company

Owner Shares% of PortfolioAs Of
1. GENEVA INVESTMENT MANAGEMENT OF CHICAGO LLC 401,252 N/A June 30, 2017

Elite Pharmaceuticals Inc. (ELTP)

140

cctranscripts

Nov. 9, 2017

Elite Pharmaceuticals Inc. Just Filed Its Quarterly Report: NOTE 22. SUBSEQUE... http://www.conferencecalltranscripts.org/pink/summary?id=4310566

cctranscripts

Nov. 9, 2017

Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2018 Ended September 30, 2017 http://www.otcmarkets.com/stock/ELTP/news?id=174871

cctranscripts

Nov. 9, 2017

Elite Pharmaceuticals, Inc. Reports Financial Results For The Second Quarter Of Fiscal Year 2018 http://www.conferencecalltranscripts.org/pink/summary?id=4307951

cctranscripts

Nov. 7, 2017

Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss Second Quarter Financial Results on September 10, 2017 http://www.otcmarkets.com/stock/ELTP/news?id=174476

cctranscripts

Nov. 7, 2017

CORRECTING and REPLACING – Elite Pharmaceuticals, Inc. http://www.otcmarkets.com/stock/ELTP/news?id=174521

cctranscripts

Oct. 11, 2017

Confidential treatment order http://www.conferencecalltranscripts.org/pink/summary?id=4216257

cctranscripts

Sept. 20, 2017

Elite Pharmaceuticals Files ANDA for Oxycodone Hydrochloride Extended Release http://www.otcmarkets.com/stock/ELTP/news?id=170291

cctranscripts

Sept. 7, 2017

Caution Concerning Forward Looking http://www.conferencecalltranscripts.org/pink/summary?id=4127188

cctranscripts

Aug. 30, 2017

Elite Pharmaceuticals to Present ELI-200 (SequestOx™) Data at PAINWeek 2017 National Conference http://www.otcmarkets.com/stock/ELTP/news?id=168535

cctranscripts

Aug. 9, 2017

Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2018 Ended June 30, 2017 and Provides Conference Call Information http://www.otcmarkets.com/stock/ELTP/news?id=166815

cctranscripts

Aug. 9, 2017

Elite Pharmaceuticals Inc. Just Filed Its Quarterly Report: The following i... http://www.conferencecalltranscripts.org/pink/summary?id=4036750

cctranscripts

Aug. 9, 2017

Elite Pharmaceuticals, Inc. Reports Financial Results For The First Quarter Of Fiscal Year 2018 Ended June 30, 2017 And Provides Conference Call Information http://www.conferencecalltranscripts.org/pink/summary?id=4037073

cctranscripts

Aug. 8, 2017

Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss First Quarter Financial Results on August 10, 2017 http://www.otcmarkets.com/stock/ELTP/news?id=166576

cctranscripts

July 28, 2017

Elite Pharmaceuticals: Elite Announces Co-Development Of Four Additional Products With Sungen Pharma http://www.conferencecalltranscripts.org/pink/summary?id=3998919

cctranscripts

July 28, 2017

Elite Announces Co-Development of Four Additional Products with SunGen Pharma http://www.otcmarkets.com/stock/ELTP/news?id=165713

cctranscripts

July 12, 2017

Elite Pharmaceuticals: Elite Announces New Development And License Agreement With Sungen Pharma Llc http://www.conferencecalltranscripts.org/pink/summary?id=3959301

cctranscripts

July 12, 2017

Confidential treatment order http://www.conferencecalltranscripts.org/pink/summary?id=3959580

cctranscripts

July 12, 2017

Elite Announces New Development and License Agreement with SunGen Pharma LLC http://www.otcmarkets.com/stock/ELTP/news?id=164373

cctranscripts

July 7, 2017

Elite Pharmaceuticals Reports Topline Results from a Pivotal Fed Bioequivalence Study for SequestOx™ http://www.otcmarkets.com/stock/ELTP/news?id=164043

cctranscripts

July 7, 2017

Elite Pharmaceuticals Reports Topline Results From A Pivotal Fed Bioequivalence Study For Sequestox™ http://www.conferencecalltranscripts.org/pink/summary?id=3950259
 


Feedback